
Glenmark Pharmaceuticals Limited has informed the Exchange about press release dated 31-Oct-2022 titled Glenmark Pharmaceuticals launches Fingolimod Capsules, 0.5 mg in the US
Filed with NSE ·

Glenmark Pharmaceuticals Limited has informed the Exchange about press release dated 31-Oct-2022 titled Glenmark Pharmaceuticals launches Fingolimod Capsules, 0.5 mg in the US
6ix hasn’t read this filing yet.
Glenmark Pharmaceuticals Limited on 6ix
Follow Glenmark Pharmaceuticals into a list and get an email when it puts out news.
Follow Glenmark Pharmaceuticals